Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Lyumjev ® ▼ (insulin lispro)
Can patients treated with Lyumjev®▼ (insulin lispro) receive COVID-19 vaccines?
The use of vaccines against SARS-CoV-2 in patients treated with Lyumjev has not been studied.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that has caused the recent COVID-19 pandemic (coronavirus disease 2019, COVID). Recently, vaccines have been developed against SARS-CoV-2 and additional vaccines are expected to be available in the coming months.1-3
SARS-CoV-2 Vaccination With Lyumjev
The use of a SARS-CoV-2 vaccine in patients treated with Lyumjev has not been studied by Eli Lilly and Company.
Decisions regarding the use of any vaccination, including SARS-CoV-2 vaccines, in patients treated with Lyumjev should be made at the discretion of the prescribing physician using their best clinical judgment, and must be made by the clinician after careful consideration of risk factors of the patient as well as the risks and benefits of vaccination.
Possible impact of vaccination on blood glucose concentration
The International Diabetes Federation IDF states that after any vaccination the blood glucose levels might rise for a few days.4
Further resources on COVID-19 Vaccines and Diabetes
For information on COVID-19 vaccines and diabetes, please refer to
For current information on COVID-19 and COVID-19 vaccines in gereral, please refer to the website of
the World Health Organization (Europen regional office) at Coronavirus disease (COVID-19) outbreak, and
1. Dong Y, Dai T, Wei Y, et al. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther. 2020;5(1):237. https://doi.org/10.1038/s41392-020-00352-y
2. Jackson LA, Anderson EJ, Rouphael NG, et al; mRNA-1273 Study Group. An mRNA vaccine against SARS-CoV-2 — preliminary report. N Engl J Med. 2020;383(20):1920-1931. https://doi.org/10.1056/NEJMoa2022483
3. COVID-19 vaccines. Centers for Disease Control and Prevention. Updated December 31, 2020. Accessed January 4, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html
4. International Diabetes Federation Europe. Diabetes & Coronavirus Vaccination. https://idf.org/our-network/regions-members/europe/europe-news/370-diabetes-coronavirus-vaccination.html. Accessed April 29, 2021
5. Coronavirus disease (COVID-19) outbreak. European web page of the World Health Organization. Accessed March 20, 2020. http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19
6. COVID-19. European Centre for Disease Prevention and Control. Accessed March 20, 2020. https://www.ecdc.europa.eu/en/novel-coronavirus-china
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Date of Last Review: January 04, 2021